Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download Microsoft EdgeDownload Microsoft Edge

Clinically led.
Evidence based.
AI powered.

The need for safe remote monitoring during the COVID-19 epidemic

As the need for remote health monitoring intensifies during the COVID-19 epidemic, Sensyne Health are developing and deploying products that enable patient groups to record their health information and be safely managed at home, clinicians to deliver continued contact and care, and healthcare organisations such as the NHS to reduce pressure on their resources.

Data generated from these products contributes to medical research aimed at predicting, diagnosing, treating and preventing a variety of conditions including COVID-19 infection.

Clinically led. Evidence based. AI powered.

A new approach that benefits life sciences, NHS and patients

Sensyne Health is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts.

These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance.

Sensyne Health was an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

How we work

Software Products

Software Products

Our software products connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research and improving patient outcomes.

Discovery Sciences

Discovery Sciences

Our Discovery Sciences team build datasets of anonymised patient data in collaboration with the NHS, providing a rich source of clinical information whilst protecting patient privacy.

Collaboration with the NHSCollaboration with the NHS


We collaborate with NHS Trusts under Strategic Research Agreements to combine patient data with clinical AI technology to improve our understanding of disease and treatment.

Our people

We’re building the best team from across the fields of AI, digital health and life sciences to help us accelerate medical research and improve patient care.
Meet our Leadership Team

Sensyne Health’s proven team has built multiple £500m+ health & technology businesses over the past 15 years. These include IPO, M&A experience in regulated healthcare and digital technologies, and is complemented by a multi-disciplinary team which combines AI expertise with deep clinical experience.